Filing Flows › GSK (GSK) › Q2 2025
GSK (GSK) Q2 2025 earnings results (second quarter 2025)
6-K filed Jul 30, 2025
GSK (GSK) reported revenue of $8.0B for the second quarter 2025 (Q2 2025), +1% from a year earlier. Operating margin was 25.3%, net earnings $1.4B (18.1% of revenue).
GSK, Q2 2025: revenue $8.0B (+1% year over year), operating margin 25.3%, net earnings $1.4B, operating cash flow $2.4B. The chart follows the revenue to costs, profit and cash.
| Q2 2025 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $8.0B | — | +1% |
| Gross profit | $5.8B | — | +1% |
| Operating profit | $2.0B | — | +23% |
| Net earnings | $1.4B | — | +23% |
| Operating cash flow | $2.4B | — | 52× |
What changed
Revenue was £8.0B in Q2 2025, up 1% year over year. HIV was the largest line at 24% of revenue.
Gross margin was 72.9%, down 0.2 points from a year earlier. Operating profit was £2.0B, a 25.3% margin (up 4.5 points year over year). Of the extra revenue versus a year earlier, 370% reached operating profit, above the 21% margin then. Operating expenses fell 8% while revenue rose 1%. Net earnings were £1.4B, up 23% year over year. The effective tax rate was 12.8%.
Operating cash flow was £2.4B (up 5077% year over year), 148% of net income including minority interests. Working capital and other items added £0.79B.
Questions
What was GSK's revenue in the second quarter 2025?
GSK (GSK) reported revenue of $8.0B for the second quarter 2025 (Q2 2025), +1% from a year earlier.
Was GSK profitable in the second quarter 2025?
Operating profit was $2.0B (25.3% of revenue) and net earnings $1.4B.
Source: GSK 6-K on SEC EDGAR.